Fabry disease in a renal allograft

被引:24
|
作者
Puliyanda, DP [1 ]
Wilcox, WR [1 ]
Bunnapradist, S [1 ]
Nast, CC [1 ]
Jordan, SC [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Div Med Genet,Ctr Kidney Dis & Transplantat, Cedars Sinai Med Ctr,Dept Renal Pathol, Los Angeles, CA 90024 USA
关键词
alpha galactosidase A; Fabry disease; focal sclerosis; heterozygote; kidney transplantation; proteinuria;
D O I
10.1034/j.1600-6143.2003.00139.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Incidental findings of rare diseases in organ donors can be seen in allograft biopsies that may have profound implications for the recipient and for the donor and their family. Fabry disease is an X-linked recessive lipid storage disease with cardiovascular, renal and lenticular abnormalities. Phenotypic expression in female heterozygote carriers depends on lyonization. Minimal data exists on outcomes of transplanted kidneys from carriers of Fabry disease. We report a patient with ESRD secondary to focal sclerosis who received a HLA-identical transplant from her sister whose pretransplant donor work up was completely negative. Post-transplant, while pregnant, the recipient developed increasing proteinuria and was biopsied. The biopsy showed extensive myelin figures consistent with Fabry disease. Subsequent genetic, enzymatic and pedigree analysis confirmed the diagnosis in the recipient, the donor and the donor's son. Two years post-transplant the patient continues to have non-nephrotic range proteinuria with normal serum creatinine.
引用
收藏
页码:1030 / 1032
页数:3
相关论文
共 50 条
  • [1] Unexpected Fabry Disease in a Renal Allograft Kidney: An Underrecognized Cause of Poor Allograft Function
    Kochar, Olga
    Wick, Mark R.
    Kerr, Sarah E.
    Oglesbee, Devin
    Cathro, Helen P.
    [J]. ULTRASTRUCTURAL PATHOLOGY, 2011, 35 (02) : 92 - 96
  • [2] Allograft loss in renal transplant recipients with Fabry's disease and activated protein C resistance
    Friedman, GS
    Wik, D
    Silva, L
    Abdou, JC
    Meier-Kriesche, HU
    Kaplan, B
    Bonomini, L
    DeFranco, P
    Lyman, N
    Mulgaonkar, S
    Jacobs, M
    [J]. TRANSPLANTATION, 2000, 69 (10) : 2099 - 2102
  • [3] Pathomechanisms of renal Fabry disease
    Eikrem, Oystein
    Skrunes, Rannveig
    Tondel, Camilla
    Leh, Sabine
    Houge, Gunnar
    Svarstad, Einar
    Marti, Hans-Peter
    [J]. CELL AND TISSUE RESEARCH, 2017, 369 (01) : 53 - 62
  • [4] Renal pathology in Fabry disease
    Alroy, J
    Sabnis, S
    Kopp, JB
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : S134 - S138
  • [5] Renal disease in Fabry patients
    Grünfeld, JP
    Lidove, O
    Joly, D
    Barbey, F
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 : 71 - 74
  • [6] Renal involvement in Fabry disease
    Kantola, Ilkka M.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (09) : 1435 - 1437
  • [7] Renal Complications of Fabry Disease
    Basic-Jukic, Nikolina
    Kes, Petar
    Coric, Marijana
    Basic-Kes, Vanja
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 6046 - 6050
  • [8] Pathomechanisms of renal Fabry disease
    Øystein Eikrem
    Rannveig Skrunes
    Camilla Tøndel
    Sabine Leh
    Gunnar Houge
    Einar Svarstad
    Hans-Peter Marti
    [J]. Cell and Tissue Research, 2017, 369 : 53 - 62
  • [9] Allograft loss in renal transplant recipients with Fabry's disease and activated protein C resistance.
    Friedman, GS
    Abdou, JC
    Silva, L
    Wik, D
    Jacobs, M
    Kaplan, B
    Meier-Kreische, HU
    Fletcher, HS
    [J]. TRANSPLANTATION, 2000, 69 (08) : S323 - S323
  • [10] Renal disease in the allograft recipient
    Nevens, Frederik
    Pirenne, Jacques
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2020, 46-47